Concepedia

Brian D. Cholewa

BD

4

Publications

166

Citations

4

H-Index

2014

Active since

Affiliations

University of California, San Francisco(Current)

Rudolfinerhaus Hospital

University of Turin

William S. Middleton Memorial Veterans Hospital

Cancer Research Center

Brian D. Cholewa is an author at University of California, San Francisco specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyTumor BiologyCell SignalingCancer ResearchRadiation OncologyHealthOncologyPhysiologyProteomics

Publications per year

2014–2016

4

Publications

4

Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma

Christian Posch, Brian D. Cholewa, Igor Vujic et al. · Journal of Investigative Dermatology · 2015 · 63 citations · Full text

Medicine, Melanoma, Immune Checkpoint Inhibitor +7

Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF<sup>V600E</sup> Mutant Melanoma Cells

Brian D. Cholewa, Molly C. Pellitteri-Hahn, Cameron O. Scarlett et al. · Journal of Proteome Research · 2014 · 38 citations · Full text

Proteomic Technology, Tumor Biology, Medicine +14

Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells

Christian Posch, Martina Sanlorenzo, Igor Vujic et al. · Journal of Investigative Dermatology · 2016 · 34 citations

Ck2α Kinase Levels, Mutant Melanocytes Reveal, Signal Transduction +10

Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo

Brian D. Cholewa, Mary A. Ndiaye, Wei Huang et al. · Cancer Letters · 2016 · 31 citations · Full text

Tumor Biology, Medicine, Receptor Tyrosine Kinase +12

Rows per page

1–4 of 4